Late-breaking results from the open-label compensated MASH cirrhosis (F4c) arm of the Phase 3 MAESTRO-NAFLD-1 trial presented at the EASL…
Women can now collect their own sample from the privacy of home, no speculum required, and mail it to a…
One Verseon paper covers a new method to compensate for missing or imperfect data and another covers Verseon's AutoESSV method…
Enrollment on track in Phase 2 pivotal portion of PYNNACLE clinical trial evaluating rezatapopt as monotherapy in patients with TP53…
Jason Keyes is a veteran corporate executive within the biopharmaceutical industry who brings a breadth of leadership experience in the…
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced…
REYKJAVIK, Iceland, May 09, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and…
SOUTH SAN FRANCISCO, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational…
Significant expansion of Covera's proven COE platform launching in 2026; provider applications now open, with employer and health plan partners…
Prestigious International Award Recognizes AccessHope for AI-Assisted Solution that Connects People with Cancer to Expertise at Top Cancer Centers DUARTE,…